ND

Naimish Dhar Dwivedi

Active Director Director DIN 06494864
DIN 06494864 First appointment Feb 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2013
Shareholding value •••• Premium profile

About Naimish Dhar Dwivedi

Data last updated:

Naimish Dhar Dwivedi is a Director at Xavi Biotech Private Limited (since 2013). The company operates in Pharma. Xavi Biotech Private Limited reported revenue of ₹1.57 Cr (FY 2024).

DIN 06494864
Primary Designation Director
Industry Pharma
First Appointment 26 Feb 2013
Oldest Company Age 13 yrs
Largest company Xavi Biotech Private Limited · ₹1.57 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xavi Biotech Private Limited U74120UP2013PTC055260
Director26 Feb 20132013₹1.57 Cr (FY 2024)Active

Board colleagues of Naimish Dhar Dwivedi

Directorship timeline

Open interactive timeline →
Xavi Biotech Private Limited
Premium access

Shareholding and investment profile for Naimish Dhar Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naimish Dhar Dwivedi

Naimish Dhar Dwivedi currently holds 1 directorship: Xavi Biotech Private Limited (Director, since 26 Feb 2013, revenue ₹1.57 Cr (FY 2024)).

Naimish Dhar Dwivedi was first appointed on 26 Feb 2013 as Director at Xavi Biotech Private Limited.

The current boards of Naimish Dhar Dwivedi's companies include Amit Kumar Mishra (Xavi Biotech Private Limited), Anoop Kumar Pandey (Xavi Biotech Private Limited), Purnendu Kumar Upadhyay (Xavi Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available